Marius Pharms Llc Drug Patent Portfolio
Marius Pharms Llc owns 1 orange book drug protected by 4 US patents Given below is the list of Marius Pharms Llc's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US11617758 | Emulsion formulations | 15 Mar, 2033 | Active |
| US10576089 | Modulation of solubility, stability, absorption, metabolism, and pharmacokinetic profile of lipophilic drugs by sterols | 31 Dec, 2030 | Active |
| US10576090 | Modulation of solubility, stability, absorption, metabolism, and pharmacokinetic profile of lipophilic drugs by sterols | 31 Dec, 2030 | Active |
| US11590146 | Modulation of solubility, stability, absorption, metabolism, and pharmacokinetic profile of lipophilic drugs by sterols | 31 Dec, 2030 | Active |
Latest Legal Activities on Marius Pharms Llc's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Marius Pharms Llc.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Payment of Maintenance Fee, 4th Yr, Small Entity | 05 Sep, 2023 | US10576090 |
| Payment of Maintenance Fee, 4th Yr, Small Entity | 01 Sep, 2023 | US10576089 |
|
Patent Issue Date Used in PTA Calculation
Critical
| 04 Apr, 2023 | US11617758 |
|
Recordation of Patent Grant Mailed
Critical
| 04 Apr, 2023 | US11617758 |
|
Email Notification
Critical
| 16 Mar, 2023 | US11617758 |
|
Issue Notification Mailed
Critical
| 15 Mar, 2023 | US11617758 |
|
Email Notification
Critical
| 28 Feb, 2023 | US11590146 |
|
Recordation of Patent Grant Mailed
Critical
| 28 Feb, 2023 | US11590146 |
|
Patent Issue Date Used in PTA Calculation
Critical
| 28 Feb, 2023 | US11590146 |
|
Application Is Considered Ready for Issue
Critical
| 24 Feb, 2023 | US11617758 |
| Dispatch to FDC | 24 Feb, 2023 | US11617758 |
|
Issue Fee Payment Received
Critical
| 22 Feb, 2023 | US11617758 |
|
Issue Fee Payment Verified
Critical
| 22 Feb, 2023 | US11617758 |
|
Issue Notification Mailed
Critical
| 08 Feb, 2023 | US11590146 |
|
Application Is Considered Ready for Issue
Critical
| 31 Jan, 2023 | US11590146 |
Marius Pharms Llc's Family Patents
Marius Pharms Llc Drug List
Given below is the complete list of Marius Pharms Llc's drugs and the patents protecting them.
1. Kyzatrex
Kyzatrex is protected by 4 patents, out of which none have expired yet. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US11617758 | Emulsion formulations |
15 Mar, 2033
(8 years from now)
| Active |
| US10576089 | Modulation of solubility, stability, absorption, metabolism, and pharmacokinetic profile of lipophilic drugs by sterols |
31 Dec, 2030
(6 years from now)
| Active |
| US10576090 | Modulation of solubility, stability, absorption, metabolism, and pharmacokinetic profile of lipophilic drugs by sterols |
31 Dec, 2030
(6 years from now)
| Active |
| US11590146 | Modulation of solubility, stability, absorption, metabolism, and pharmacokinetic profile of lipophilic drugs by sterols |
31 Dec, 2030
(6 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Kyzatrex's drug page